Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

4th Glioblastoma Drug Development Summit

Evvnt Promotion / evvnt
-
14.03.2023 - 16.03.2023  Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, Massachusetts, USA
Time: 08:00 - 18:00
 
Temi della conferenza
Accelerate the Practical Translation and Clinical Development of Meaningful Therapies for the Treatment of Glioblastoma and Other Life Threatening CNS Tumors
Glioblastoma continues to be one of the most devasting diseases, with a severe lack of options available for treatment. Between drug delivery challenges, inefficient preclinical models and post-treatment recurrence, this is one of the most difficult tumors to develop treatments for.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1427445-2?pid=4832

Speakers: Adilia Hormigo, Professor in the Department of Neurology, Medicine (Division of Hematology- Oncology), Albert Einstein College of Medicine, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1427445-3?pid=4832
Ms. Aarti Diwan
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 4997.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Anästhesie in Entwicklungsländern e. V.Hilfswerk AustriaEuropean Health Forum GasteinÖsterreichische Gesellschaft für Public HealthCenter of ExcellenceCharité International AcademyAMREF - African Medical and Research FoundationAGEM - Arbeitsgemeinschaft Ethnologie und Medizin